Chronic Kidney Disease (CKD) clinical trials in California
35 active Chronic Kidney Disease (CKD) trials with a site in California. Describe your situation to see which ones look like a fit.
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
- Sit Less, Interact and Move More (SLIMM) 2 Study
- Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- Ferric Citrate and Chronic Kidney Disease in Children
- A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Pivotal Study of the Velocity™ pAVF System
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
- Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- Renal Impairment Study for Oral EC5026
- An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
- Transformative Research in Diabetic Nephropathy
- Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
- Nicotinamide Riboside Supplementation in Chronic Kidney Disease
- Refining Risk Prediction Models for Older Adults Using Electronic Health Records
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
- Patient-centered Precision Medicine Lab Result Communication for Older Adults
- Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial
- Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease
- Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Quest to Analyze One Thousand Humans Meditating
- A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.